Axogen, Inc.

US$50.02As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:AXGNHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 18.87%
Div yield —
ROE (10.35%)
Medical Devices
Beta (5Y) 1.15
PE TTM —
TSR TTM 125.11%
Mkt cap US$2.988B
ROIC (2.44%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$54
7.32%
(93.23%)
Hold 6|5|8|9|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.77
0.78
0.79
0.84
19.23%
12.70%
18.62%
13.37%
Revenue$M
236.7
236.3
246.1
240.5
12.74%
9.53%
9.81%
3.30%
Peers (US$2.988B)
Cap (US$)
PE
2.567B
—
Capital
TTM
5Y
10Y
Leveragex
0.456
—
—
EBIT/Intx
0.906
0.226
0.187
Own earn%
142.30
113.68
99.68
Sh yield%
27.41
22.23
22.07
Owners
Insiders/Inst%
12.40
35.06
Short interest%
1.35
SBC / revenue%
4.11
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
3–12
$1 testx
0.0
Incr. ROIC%
59